Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 18 studies | 60% ± 19% | |
| oligodendrocyte precursor cell | 15 studies | 91% ± 15% | |
| glutamatergic neuron | 12 studies | 72% ± 19% | |
| oligodendrocyte | 12 studies | 47% ± 15% | |
| GABAergic neuron | 11 studies | 67% ± 24% | |
| microglial cell | 9 studies | 39% ± 20% | |
| neuron | 8 studies | 36% ± 15% | |
| amacrine cell | 7 studies | 34% ± 13% | |
| interneuron | 6 studies | 60% ± 24% | |
| retinal rod cell | 6 studies | 37% ± 28% | |
| Mueller cell | 6 studies | 79% ± 26% | |
| endothelial cell | 5 studies | 47% ± 13% | |
| retinal ganglion cell | 5 studies | 63% ± 30% | |
| granule cell | 4 studies | 56% ± 15% | |
| macrophage | 3 studies | 30% ± 6% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 71% ± 19% | |
| GABAergic interneuron | 3 studies | 79% ± 1% | |
| glial cell | 3 studies | 34% ± 12% | |
| GABAergic amacrine cell | 3 studies | 57% ± 2% | |
| glycinergic amacrine cell | 3 studies | 52% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 1181.69 | 2596 / 2642 | 99% | 24.14 | 699 / 705 |
| adrenal gland | 60% | 129.52 | 156 / 258 | 83% | 10.56 | 192 / 230 |
| thymus | 79% | 169.10 | 519 / 653 | 45% | 1.38 | 272 / 605 |
| breast | 49% | 172.49 | 226 / 459 | 69% | 4.13 | 774 / 1118 |
| ovary | 17% | 29.78 | 31 / 180 | 56% | 2.01 | 240 / 430 |
| intestine | 65% | 221.51 | 630 / 966 | 6% | 0.15 | 32 / 527 |
| uterus | 46% | 98.37 | 79 / 170 | 24% | 1.24 | 108 / 459 |
| lung | 39% | 68.75 | 225 / 578 | 14% | 0.28 | 158 / 1155 |
| esophagus | 47% | 96.03 | 676 / 1445 | 5% | 0.08 | 9 / 183 |
| pancreas | 1% | 0.67 | 2 / 328 | 49% | 1.21 | 87 / 178 |
| prostate | 30% | 58.70 | 74 / 245 | 17% | 0.31 | 83 / 502 |
| heart | 42% | 103.57 | 364 / 861 | 0% | 0 | 0 / 0 |
| bladder | 33% | 71.19 | 7 / 21 | 8% | 0.24 | 40 / 504 |
| blood vessel | 36% | 80.68 | 483 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 20% | 43.03 | 72 / 359 | 10% | 0.23 | 29 / 286 |
| kidney | 9% | 13.69 | 8 / 89 | 17% | 0.66 | 157 / 901 |
| adipose | 23% | 42.37 | 280 / 1204 | 0% | 0 | 0 / 0 |
| liver | 6% | 8.36 | 13 / 226 | 5% | 0.11 | 20 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.15 | 3 / 29 |
| skin | 1% | 1.76 | 25 / 1809 | 7% | 0.31 | 35 / 472 |
| spleen | 6% | 8.14 | 14 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.11 | 3 / 80 |
| peripheral blood | 3% | 5.15 | 29 / 929 | 0% | 0 | 0 / 0 |
| muscle | 2% | 2.55 | 16 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0099560 | Biological process | synaptic membrane adhesion |
| GO_0050804 | Biological process | modulation of chemical synaptic transmission |
| GO_0050770 | Biological process | regulation of axonogenesis |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005615 | Cellular component | extracellular space |
| GO_0098839 | Cellular component | postsynaptic density membrane |
| GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0050839 | Molecular function | cell adhesion molecule binding |
| GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LRRC4C |
| Protein name | Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1) Leucine rich repeat containing 4C |
| Synonyms | KIAA1580 NGL1 UNQ292/PRO331 |
| Description | FUNCTION: May promote neurite outgrowth of developing thalamic neurons. . |
| Accessions | ENST00000528697.6 E9PLP4 ENST00000619527.4 ENST00000278198.2 ENST00000530763.5 Q9HCJ2 ENST00000533474.1 ENST00000527150.5 |